Skip to main content

Table 2 The incidence of AEs in the included studies

From: Indirect-comparison meta-analysis of treatment options for patients with refractory Kawasaki disease

 

Infliximab group (%)

 

IVMP group (%)

Variable

Burns

Youn

Tremoulet

Son

Masaaki

Miura05

Miura08

Teraguchi

Sundel

Newburger

Transient hepatomegaly

41.7

–

–

19

 

–

–

–

–

–

Chills

–

0

–

–

 

–

–

–

6

–

Rash

–

10

1

–

12.5

–

–

–

–

–

Headache

–

–

2

–

 

–

–

–

–

5

Hemolytic anemia

–

–

2

–

 

–

–

–

–

1

Seizure

–

–

0

–

 

–

–

–

–

–

Hepatitis

–

–

0

–

 

–

–

–

–

–

Hypertension

–

–

0

–

 

90

86

–

6

–

Coagulopathy

–

–

0

–

 

27

–

–

–

–

Bradycardia

–

–

–

–

 

82

86

–

–

–

Hypothermia

–

–

–

–

 

1

14

–

–

–

Hypotension

–

–

–

–

 

–

–

–

–

5

Hyperglycemia

–

–

–

–

 

55

71

–

–

–

Embolism

–

–

–

–

 

0

0

–

–

–

Stool blood

–

–

–

–

 

0

0

7

–

–

Vomiting

–

–

–

–

6.3

–

–

–

0

–

Heart failure

–

–

–

–

 

–

–

–

0

0

Shock

–

–

–

–

 

–

–

–

–

1